Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1325 8 |
Ultima descărcare din IBN: 2024-04-23 02:58 |
SM ISO690:2012 DAVID, Ludmila, GHICAVÂI, Victor, BUTOROV, Ivan, STOLEAR, Anton, BUTOROV, Valentina, NECULA, Gheorghe. Aspecte clinico-farmacologice ale heptralului în tratamentul steatohepatitei non-alcoolice. In: Curierul Medical, 2010, nr. 3(315), pp. 98-104. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 3(315) / 2010 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 98-104 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Clinical and Pharmacological Aspects of Heptral in the Treatment of Non-alcoholic Steatohepatitis
The study included 50 patients with NASH. Among them were 15 men and 35 women. Initially all patients had abdominal type obesity.
Overweight body mass was diagnosed in 5 patients, 5 – I degree obesity, 8 – II degree, 7 – degree III and IV. Heptral is a pharmaceutical
preparation with positive influence on the main pathogenetic links of steatohepatitis. Including Heptral in the complex therapy of patients with
non-alcoholic steatohepatitis decreased the activity of enzymes of cytolysis, significantly improved the lipid peroxidation and hormonal status
indices in comparison with the basic therapy. Heptral also improved patients’ quality of life. |
||||||
Cuvinte-cheie Heptral, non-alcoholic steatohepatitis |
||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>David, L.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Ghicavâi, V.I.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Butorov, I.V.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Stolear, A.</creatorName> </creator> <creator> <creatorName>Butorov, V.G.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Necula, G.</creatorName> </creator> </creators> <titles> <title xml:lang='ro'>Aspecte clinico-farmacologice ale heptralului în tratamentul steatohepatitei non-alcoolice</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2010</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1875-0666</relatedIdentifier> <subjects> <subject>Heptral</subject> <subject>non-alcoholic steatohepatitis</subject> </subjects> <dates> <date dateType='Issued'>2010-06-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'>Clinical and Pharmacological Aspects of Heptral in the Treatment of Non-alcoholic Steatohepatitis The study included 50 patients with NASH. Among them were 15 men and 35 women. Initially all patients had abdominal type obesity. Overweight body mass was diagnosed in 5 patients, 5 – I degree obesity, 8 – II degree, 7 – degree III and IV. Heptral is a pharmaceutical preparation with positive influence on the main pathogenetic links of steatohepatitis. Including Heptral in the complex therapy of patients with non-alcoholic steatohepatitis decreased the activity of enzymes of cytolysis, significantly improved the lipid peroxidation and hormonal status indices in comparison with the basic therapy. Heptral also improved patients’ quality of life.</description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>